Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Health Network, Toronto
- Trial code
- NCT06220526
- Record updated
- 1 May 2026
- Original description
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.Read full original descriptionShow less
A Prospective Randomized Clinical Trial Comparing Menghini-type Needle and Franseen-type Needle for Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Pathological Diagnosis of Sarcoidosis
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.
Inclusion: -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes; (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical; history, physical exam, and other investigations, and booked for EBUS-TBNA.
Exclusion: -Patients that are unable to provide informed consent; Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on; clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,; infection).